MedPath

A Clinical trial to study the effect of fentanyl and buprenorphine in spinal anesthesia to decrease the post-operative pain in patients undergoing lower abdominal surgeries.

Phase 4
Conditions
Health Condition 1: K421- Umbilical hernia with gangrene
Registration Number
CTRI/2024/01/061835
Lead Sponsor
Mahatma Gandhi Institute Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

American Society of Anesthesiologist Grade I and II patients.

Age 18-65 years of either gender.

Patients undergoing infraumbilical Surgeries.

Height is more than 4 feet.

Patients willing to give consent.

Exclusion Criteria

American Society of Anesthesiologists Grade III and IV patients.

Patients with known contraindications for spinal anesthesia: bleeding disorders, local infection.

Patients with cardiovascular instability.

Patients with comorbidities like Hypertension, Diabetes Mellitus, cardiac diseases, etc.

Patient with allergy to opioids or history of hypersensitivity to local anesthetics.

Emergency surgeries.

Patients with a history of severe PDPH or PONV after spinal anesthesia.

Patients not willing to give informed written consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the duration of sensory & motor blockade.Timepoint: 15min 30min 45min
Secondary Outcome Measures
NameTimeMethod
1. The onset of sensory & motor blocks was achieved. <br/ ><br>2.The level of blockade achieved. <br/ ><br>3. The efficacy of postoperative analgesia. <br/ ><br>4. Side effects like hemodynamic changes (hypotension and bradycardia) sedation, pruritus, post-operative nausea and vomiting and respiratory depression. <br/ ><br>Timepoint: 15min, 30min,45min
© Copyright 2025. All Rights Reserved by MedPath